Literature DB >> 18528402

Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome.

S Belanger1, L-H Tai, S K Anderson, A P Makrigiannis.   

Abstract

The mouse Ly49 and human killer cell immunoglobulin-like receptors (KIR) gene clusters encode activating and inhibitory class I MHC receptors on natural killer (NK) cells. A direct correlation between the presence of multiple activating KIR and various human autoimmune diseases including diabetes has been shown. Previous studies have implicated NK cell receptors in the development of diabetes in the non-obese diabetic (NOD) inbred mouse strain. To assess the contribution of Ly49 to NOD disease acceleration the Ly49 gene cluster of these mice was sequenced. Remarkably, the NOD Ly49 haplotype encodes the largest haplotype and the most functional activating Ly49 of any known mouse strain. These activating Ly49 include three Ly49p-related and two Ly49h-related genes. The NOD cluster contains large regions highly homologous to both C57BL/6 and 129 haplotypes, suggesting unequal crossing over as a mechanism of Ly49 haplotype evolution. Interestingly, the 129-like region has duplicated in the NOD genome. Thus, the NOD Ly49 cluster is a unique mix of elements seen in previously characterized Ly49 haplotypes resulting in a disproportionately large number of functional activating Ly49 genes. Finally, the functionality of activating Ly49 in NOD mice was confirmed in cytotoxicity assays.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18528402      PMCID: PMC2678550          DOI: 10.1038/gene.2008.43

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  51 in total

1.  Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion.

Authors:  L H Mason; J Willette-Brown; A T Mason; D McVicar; J R Ortaldo
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

Review 2.  NK cells: elusive players in autoimmunity.

Authors:  Sofia Johansson; Louise Berg; Håkan Hall; Petter Höglund
Journal:  Trends Immunol       Date:  2005-08-22       Impact factor: 16.687

Review 3.  The stages of type 1A diabetes.

Authors:  Naru Babaya; Maki Nakayama; George S Eisenbarth
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 4.  NOD mice and autoimmunity.

Authors:  Christopher A Aoki; Andrea T Borchers; William M Ridgway; Carl L Keen; Aftab A Ansari; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2005-03-29       Impact factor: 9.754

Review 5.  Type 1 diabetes genes and pathways shared by humans and NOD mice.

Authors:  Linda S Wicker; Jan Clark; Heather I Fraser; Valerie E S Garner; Andrea Gonzalez-Munoz; Barry Healy; Sarah Howlett; Kara Hunter; Dan Rainbow; Raymond L Rosa; Luc J Smink; John A Todd; Laurence B Peterson
Journal:  J Autoimmun       Date:  2005-10-28       Impact factor: 7.094

6.  Altered natural killer cells in type 1 diabetic patients.

Authors:  Melanie Rodacki; Britta Svoren; Vincent Butty; Whitney Besse; Lori Laffel; Christophe Benoist; Diane Mathis
Journal:  Diabetes       Date:  2007-01       Impact factor: 9.461

7.  Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein.

Authors:  Agnieszka Kielczewska; Hee-Seo Kim; Lewis L Lanier; Nazzareno Dimasi; Silvia M Vidal
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

8.  Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype.

Authors:  S K Anderson; K Dewar; M-L Goulet; G Leveque; A P Makrigiannis
Journal:  Genes Immun       Date:  2005-09       Impact factor: 2.676

9.  Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice.

Authors:  Yoshihiro Inoue; Tomonori Kaifu; Akiko Sugahara-Tobinai; Akira Nakamura; Jun-Ichi Miyazaki; Toshiyuki Takai
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

10.  Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta.

Authors:  A Alba; R Planas; X Clemente; J Carrillo; R Ampudia; M-C Puertas; X Pastor; E Tolosa; R Pujol-Borrell; J Verdaguer; M Vives-Pi
Journal:  Clin Exp Immunol       Date:  2008-01-08       Impact factor: 4.330

View more
  22 in total

1.  Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice.

Authors:  Simon Bélanger; Megan M Tu; Mir Munir Ahmed Rahim; Ahmad B Mahmoud; Rajen Patel; Lee-Hwa Tai; Angela D Troke; Brian T Wilhelm; Josette-Renée Landry; Qinzhang Zhu; Kenneth S Tung; David H Raulet; Andrew P Makrigiannis
Journal:  Blood       Date:  2012-06-01       Impact factor: 22.113

2.  A defective Il15 allele underlies the deficiency in natural killer cell activity in nonobese diabetic mice.

Authors:  Hirotsugu Suwanai; Martha Angela Wilcox; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

Review 3.  Transcriptional and epigenetic networks of helper T and innate lymphoid cells.

Authors:  Han-Yu Shih; Giuseppe Sciumè; Amanda C Poholek; Golnaz Vahedi; Kiyoshi Hirahara; Alejandro V Villarino; Michael Bonelli; Remy Bosselut; Yuka Kanno; Stefan A Muljo; John J O'Shea
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

4.  Regulation of Diabetogenic Immunity by IL-15-Activated Regulatory CD8 T Cells in Type 1 Diabetes.

Authors:  Blair T Stocks; Christopher S Wilson; Andrew F Marshall; Emilee M Hoopes; Daniel J Moore
Journal:  J Immunol       Date:  2019-05-24       Impact factor: 5.422

5.  Natural killer cells in NOD.NK1.1 mice acquire cytolytic function during viral infection and provide protection against cytomegalovirus.

Authors:  Mark T Orr; Joshua N Beilke; Irina Proekt; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

6.  The activating Ly49W and inhibitory Ly49G NK cell receptors display similar affinities for identical MHC class I ligands.

Authors:  Brian J Ma; Carla M Craveiro Salvado; Kevin P Kane
Journal:  Immunogenetics       Date:  2014-05-07       Impact factor: 2.846

7.  The mouse NKR-P1B:Clr-b recognition system is a negative regulator of innate immune responses.

Authors:  Mir Munir A Rahim; Peter Chen; Amelia N Mottashed; Ahmad Bakur Mahmoud; Midhun J Thomas; Qinzhang Zhu; Colin G Brooks; Vicky Kartsogiannis; Matthew T Gillespie; James R Carlyle; Andrew P Makrigiannis
Journal:  Blood       Date:  2015-01-22       Impact factor: 22.113

8.  Effects of MHC class I alleles on licensing of Ly49A+ NK cells.

Authors:  A Helena Jonsson; Liping Yang; Sungjin Kim; Samantha M Taffner; Wayne M Yokoyama
Journal:  J Immunol       Date:  2010-03-01       Impact factor: 5.422

9.  The distal upstream promoter in Ly49 genes, Pro1, is active in mature NK cells and T cells, does not require TATA boxes, and displays enhancer activity.

Authors:  Frances Gays; Sally Taha; Colin G Brooks
Journal:  J Immunol       Date:  2015-04-29       Impact factor: 5.422

10.  Evidence for high bi-allelic expression of activating Ly49 receptors.

Authors:  Arefeh Rouhi; C Benjamin Lai; Tammy P Cheng; Fumio Takei; Wayne M Yokoyama; Dixie L Mager
Journal:  Nucleic Acids Res       Date:  2009-07-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.